These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 687752)

  • 21. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of acute leukemias].
    Brilliant MD
    Ter Arkh; 1973 Sep; 45(9):72-85. PubMed ID: 4585646
    [No Abstract]   [Full Text] [Related]  

  • 23. [Letter: Acute lymphoid leukemia: constant induction of remission by the combination of prednisone, vincristine and L-asparaginase (20 cases)].
    Mathe G; Pouillart P; De Vassal F; Delgado M; Schwarzenberg L; Misset JL; Hayat M; Jasmin C; Belpomme D; Musset M
    Nouv Presse Med; 1976 Jun; 5(23):1491. PubMed ID: 1064849
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
    Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA; Marcar JR; Schretlen ED
    Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
    [No Abstract]   [Full Text] [Related]  

  • 26. [Complete remission obtained in refractory acute lymphocytic leukemia using high-dose cytosine arabinoside combined with low-dose L-asparaginase].
    Inagaki C; Ito K; Omori I; Shimazaki C; Nishio A; Haruyama H; Isemura T; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):379-82. PubMed ID: 3855616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate/L-asparaginase combination chemotherapy for patients with acute leukemia in relapse: a study of 36 children.
    Harris RE; McCallister JA; Provisor DS; Weetman RM; Baehner RL
    Cancer; 1980 Nov; 46(9):2004-8. PubMed ID: 6968621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.
    Shetty PA; Kurkure PA; Dasgupta A
    Indian J Cancer; 1984; 21(1):45-9. PubMed ID: 6595214
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry].
    Tsurusawa M; Sasaki K; Matsuoka H; Katano N; Fujimoto T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1827-32. PubMed ID: 3876075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential administration of methotrexate and asparaginase in relapsed or refractory pediatric acute myeloid leukemia.
    Buaboonnam J; Cao X; Pauley JL; Pui CH; Ribeiro RC; Rubnitz JE; Inaba H
    Pediatr Blood Cancer; 2013 Jul; 60(7):1161-4. PubMed ID: 23335430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of new antileukemic agents, with special reference to L-asparaginase, and cyclic maintenance therapy in acute leukemia].
    Yamada K; Hirano M; Miura M
    Nihon Ketsueki Gakkai Zasshi; 1969 Feb; 32(1):140-2. PubMed ID: 5388875
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complete remission of lymphosarcoma cell leukemia with BACOP and L-asparaginase therapy--report of a case (author's transl)].
    Tachibana A; Kimoto M; Yamaguchi H; Asai I; Tsukada T
    Rinsho Ketsueki; 1977 Oct; 18(10):1260-5. PubMed ID: 592502
    [No Abstract]   [Full Text] [Related]  

  • 34. Maintenance therapy and pharmacokinetics of intermittent high-dose methotrexate in acute childhood leukemia.
    Fujimoto T; Hasegawa K; Take H; Miyazaki S; Kishida K
    Nihon Ketsueki Gakkai Zasshi; 1977 Feb; 40(1):119-32. PubMed ID: 577645
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose methotrexat therapy of childhood cancer--observations relating to clinical toxicity.
    Fujimoto T; Sasaki K; Goya N
    Nihon Gan Chiryo Gakkai Shi; 1978 Apr; 13(2):118-25. PubMed ID: 307037
    [No Abstract]   [Full Text] [Related]  

  • 36. Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm.
    Gilis L; Lebras L; Bouafia-Sauvy F; Espinouse D; Felman P; Berger F; Salles G; Coiffier B; Michallet AS
    Leuk Lymphoma; 2012 Aug; 53(8):1633-7. PubMed ID: 22260159
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurotoxicity of commonly used antineoplastic agents (first of two parts).
    Weiss HD; Walker MD; Wiernik PH
    N Engl J Med; 1974 Jul; 291(2):75-81. PubMed ID: 4599221
    [No Abstract]   [Full Text] [Related]  

  • 38. [Is there a special indication for the use of asparginase in patients with acute leukemia?].
    Gross R; Löffler H; Wilms K
    Med Welt; 1979 Mar; 30(11):408-10. PubMed ID: 431373
    [No Abstract]   [Full Text] [Related]  

  • 39. Electroencephalogram changes secondary to asparaginase.
    Moure JM; Whitecar JP; Bodey GP
    Arch Neurol; 1970 Oct; 23(4):365-8. PubMed ID: 5475719
    [No Abstract]   [Full Text] [Related]  

  • 40. Intrinsic and acquired resistance to methotrexate in acute leukemia.
    Gorlick R; Goker E; Trippett T; Waltham M; Banerjee D; Bertino JR
    N Engl J Med; 1996 Oct; 335(14):1041-8. PubMed ID: 8793930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.